Molecular aspects of prostate cancer with neuroendocrine differentiation
about
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.Role and underlying mechanisms of the interstitial protein periostin in the diagnosis and treatment of malignant tumors.Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.
P2860
Molecular aspects of prostate cancer with neuroendocrine differentiation
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Molecular aspects of prostate cancer with neuroendocrine differentiation
@ast
Molecular aspects of prostate cancer with neuroendocrine differentiation
@en
Molecular aspects of prostate cancer with neuroendocrine differentiation
@nl
type
label
Molecular aspects of prostate cancer with neuroendocrine differentiation
@ast
Molecular aspects of prostate cancer with neuroendocrine differentiation
@en
Molecular aspects of prostate cancer with neuroendocrine differentiation
@nl
prefLabel
Molecular aspects of prostate cancer with neuroendocrine differentiation
@ast
Molecular aspects of prostate cancer with neuroendocrine differentiation
@en
Molecular aspects of prostate cancer with neuroendocrine differentiation
@nl
P2093
P2860
P1476
Molecular aspects of prostate cancer with neuroendocrine differentiation
@en
P2093
Connie S Zhang
Yifen Zhang
P2860
P356
10.3978/J.ISSN.1000-9604.2016.01.02
P407
P577
2016-02-01T00:00:00Z